acute respiratory distress syndrome

Intravenous immunoglobulin treatment in COVID-19: friend or foe to tackle hyperinflammation? A case report

22 maart 2023

Abstract We report here a patient with neuromyelitis optica, on a maintenance therapy of rituximab and mycophenolate mofetil, with severe coronavirus disease 2019 (COVID-19) who was admitted to the ICU in April 2020. Because of the immunocompromised status, viral clearance was not achieved. Treatment with intravenous immunoglobulins was initiated to…